The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about
the clinical and pathologic diagnosis of DLB, updating the previous report, which has been …

The prodromal phase of dementia with Lewy bodies (DLB) includes (1) mild cognitive
impairment (MCI),(2) delirium-onset, and (3) psychiatric-onset presentations. The purpose of …

Dementia describes a clinical syndrome that encompasses difficulties in memory, language,
and behaviour that leads to impairments in activities of daily living. Alzheimer's disease is …

Dementia with Lewy bodies (DLB) is an age-associated neurodegenerative disorder
producing progressive cognitive decline that interferes with normal life and daily activities …

Objective: The authors examined research on effects, costs, and patient and caregiver views
of pharmacological management strategies for Lewy body dementia. Method: Studies were …

Dementia with Lewy bodies and Parkinson's disease dementia, jointly known as Lewy body
dementia, are common neurodegenerative conditions. Patients with Lewy body dementia …

Transcranial magnetic stimulation (TMS) is a powerful tool to probe in vivo brain circuits, as it
allows to assess several cortical properties such as excitability, plasticity and connectivity in …

The British Association for Psychopharmacology coordinated a meeting of experts to review
and revise its previous 2011 guidelines for clinical practice with anti-dementia drugs. As …

Objectives There is growing evidence for the role of systemic inflammation in Alzheimer's
disease (AD) and other neurodegenerative diseases; however the systemic inflammatory …

Cerebral white matter lesions (WML) encompass axonal loss and demyelination, and the
pathogenesis is assumed to be small vessel disease (SVD)-related ischemia. However …